V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20187846 | 20181477 | 1.81 | 116 | Adjuvant (A) | 2019-06-16 | 2019-06-16 | Capecitabine + Oxaliplatin 21day | N | N | CAPECITABINE + OXALIPLATIN | 101860362 |
| 20188066 | 20181478 | 1.7 | 72.3 | null | 2018-01-02 | 2018-10-11 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 101804184 |
| 20188420 | 20181480 | 1.61 | 49.6 | Palliative (P) | 2016-10-03 | 2016-10-22 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101004859 |
| 20189538 | 20181481 | 1.67 | 97 | Palliative (P) | 2017-03-25 | 2017-06-23 | FLUOROURACIL + IRINOTECAN | 02 | N | FLUOROURACIL + IRINOTECAN | 101666427 |
| 20193185 | 20181482 | 1.8 | 63.95 | Palliative (P) | 2019-05-06 | 2019-06-22 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 100860928 |
| 20193969 | 20181483 | 1.65 | 64 | null | 2019-04-17 | 2019-04-26 | FLUOROURACIL + IRINOTECAN | 02 | null | FLUOROURACIL + IRINOTECAN | 100393909 |
| 20194299 | 20181484 | 1.67 | 91.6 | Curative (C) | 2018-09-16 | 2018-10-15 | FLUOROURACIL + IRINOTECAN | 02 | null | FLUOROURACIL + IRINOTECAN | 101360416 |
| 20195507 | 20181485 | 1.65 | 87.7 | Palliative (P) | 2017-11-26 | 2018-04-13 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 100193126 |
| 20196037 | 20181486 | 1.67 | 85 | Palliative (P) | 2021-09-11 | 2021-09-29 | FLUOROURACIL + IRINOTECAN | 02 | null | FLUOROURACIL + IRINOTECAN | 100517554 |
| 20198624 | 20181487 | 1.8 | 69 | null | 2020-09-11 | 2020-09-27 | Irinotecan + Modified De Gramont | 02 | null | FLUOROURACIL + IRINOTECAN | 100957802 |
| 20199397 | 20181488 | 1.69 | 54.9 | Palliative (P) | 2018-12-16 | 2018-12-17 | Oxaliplatin + Modified de Gramont | 02 | N | FLUOROURACIL + OXALIPLATIN | 101318370 |
| 20199754 | 20181489 | 1.76 | 79.7 | Adjuvant (A) | 2019-01-20 | 2019-01-21 | Oxaliplatin + Modified de Gramont | 02 | N | FLUOROURACIL + OXALIPLATIN | 100414315 |
| 20209349 | 20181491 | 1.67 | 54.4 | Palliative (P) | 2022-03-19 | 2022-03-26 | FLUOROURACIL + OXALIPLATIN | 02 | N | FLUOROURACIL + OXALIPLATIN | 101420227 |
| 20212162 | 20181493 | 1.69 | 100 | Palliative (P) | 2022-01-31 | 2022-02-11 | Oxaliplatin + Modified de Gramont | 02 | N | FLUOROURACIL + OXALIPLATIN | 100304192 |
| 20212640 | 20181494 | 1.68 | 66 | Palliative (P) | 2021-09-14 | 2021-10-24 | Gemcitabine 1000mg/m2 D1 8 15 | null | N | GEMCITABINE | 101570229 |
| 20212783 | 20181495 | 1.74 | 73 | Palliative (P) | 2018-08-26 | 2018-08-26 | GEMCITABINE | 02 | N | GEMCITABINE | 100183131 |
| 20212923 | 20181497 | 1.7 | 72.2 | null | 2016-06-08 | 2016-08-24 | PACLITAXEL | 02 | null | PACLITAXEL | 100919768 |
| 20214060 | 20181499 | 1.73 | 87.2 | null | 2021-09-20 | 2021-10-04 | Trifluridine + Tipiracil | 02 | null | TIPIRACIL + TRIFLURIDINE | 101161973 |
| 20215623 | 20181501 | 1.75 | 58.6 | Palliative (P) | 2020-11-05 | 2021-10-11 | Folfirinox | 02 | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100882737 |
| 20216110 | 20181502 | 1.85 | 53 | Palliative (P) | 2020-09-11 | 2020-09-17 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 02 | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100655310 |
| 20216538 | 20181505 | 1.62 | 92.6 | null | 2016-12-30 | 2017-01-01 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100368325 |
| 20216669 | 20181506 | 0 | 0 | null | 2021-08-04 | 2021-11-27 | FLUOROURACIL + FOLINIC ACID | 01 | Y | TRIAL UNSPECIFIED | 101816080 |
| 20217989 | 20181507 | 1.71 | 64.1 | null | 2016-11-08 | 2018-04-12 | CISPLATIN + GEMCITABINE | 02 | null | CISPLATIN + GEMCITABINE | 101038346 |
| 20218111 | 20181508 | 1.49 | 74.7 | null | 2017-05-14 | 2017-05-14 | CISPLATIN + GEMCITABINE | N | null | CISPLATIN + GEMCITABINE | 100856685 |
| 20220179 | 20181510 | 1.72 | 72.6 | Palliative (P) | 2020-01-04 | 2020-01-11 | CISPLATIN + GEMCITABINE | 02 | N | CISPLATIN + GEMCITABINE | 101150997 |
| 20220243 | 20181511 | null | 79.9 | Neo-adjuvant (N) | 2020-09-30 | 2020-10-04 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100340220 |
| 20222025 | 20181512 | 1.63 | 103.7 | Neo-adjuvant (N) | 2020-10-26 | 2020-11-01 | Docetaxel | 02 | N | DOCETAXEL | 100851418 |
| 20224037 | 20181513 | 1.88 | 82.8 | Palliative (P) | 2018-08-22 | 2018-08-31 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101596662 |
| 20224653 | 20181514 | 1.68 | 59.3 | null | null | 2019-09-15 | Capecitabine + Cisplatin + RT | 02 | null | CAPECITABINE + CISPLATIN | 100633752 |
| 20224935 | 20181515 | 1.77 | 68.2 | Palliative (P) | 2016-09-19 | 2016-10-04 | CETUXIMAB | 02 | N | CETUXIMAB | 100659852 |
| 20022145 | 20181516 | 1.84 | 64.6 | Palliative (P) | 2020-09-06 | 2021-06-17 | CETUXIMAB | 2 | N | CAPECITABINE + CISPLATIN | 101355962 |
| 20031197 | 20181517 | 1.75 | 97.4 | null | 2019-07-02 | 2019-07-26 | Irinotecan 14day | 02 | null | IRINOTECAN | 101805692 |
| 20032626 | 20181518 | 1.72 | 108.9 | Palliative (P) | 2020-10-13 | 2020-10-28 | FLUOROURACIL + IRINOTECAN | 02 | N | IRINOTECAN + MDG | 101198710 |
| 20036226 | 20181519 | 1.77 | 55 | Palliative (P) | 2018-04-08 | 2018-04-25 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101801977 |
| 20038481 | 20181520 | 1.81 | 65.5 | Curative (C) | 2021-06-02 | 2021-08-06 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100229133 |
| 20047432 | 20181521 | 1.62 | 58 | Palliative (P) | 2022-04-16 | 2022-04-16 | null | 02 | N | NIVOLUMAB | 101205070 |
| 20048023 | 20181522 | 1.81 | 90.3 | null | 2019-06-10 | 2019-08-23 | Panitumumab | 02 | null | PANITUMUMAB | 100262178 |
| 20052570 | 20181523 | 1.52 | 58.05 | Curative (C) | 2018-01-13 | 2018-01-28 | NIVOLUMAB | 2 | N | NIVOLUMAB | 101319743 |
| 20078985 | 20181525 | 1.79 | 55.6 | Palliative (P) | 2020-12-24 | 2021-01-01 | FLUOROURACIL + IRINOTECAN + Panitumumab | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100782911 |
| 20111191 | 20181526 | 1.56 | 91.3 | Palliative (P) | 2020-11-21 | 2021-10-24 | Cetuximab + FOLFIRI cycle 2 onwards | 1 | null | CETUXIMAB + IRINOTECAN + MDG | 100997276 |
| 20124005 | 20181528 | 0 | 52.4 | null | 2021-02-02 | 2021-02-22 | null | 02 | null | LANREOTIDE | 101570061 |
| 20155475 | 20181529 | 0 | null | null | 2022-02-18 | 2022-03-14 | LENVATINIB | 02 | null | LENVATINIB | 101204404 |
| 20169180 | 20181530 | 0 | 69.6 | 03 | 2017-09-08 | 2018-03-23 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | FLUOROURACIL + MITOMYCIN | 100813839 |
| 20201314 | 20181532 | 0 | 71.5 | Palliative (P) | 2018-09-16 | 2018-11-07 | Panitumumab +Oxaliplatin +MdG | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101256435 |
| 20203204 | 20181533 | 1.52 | null | Palliative (P) | 2022-03-19 | 2022-03-24 | null | 02 | N | LUTETIUM-177 | 101602500 |
| 20206048 | 20181535 | 1.69 | 67.4 | null | 2020-02-29 | 2020-03-02 | null | 02 | null | CARBOPLATIN + FLUOROURACIL | 101257517 |
| 20214585 | 20181538 | 1.66 | 75.9 | Curative (C) | 2018-06-30 | 2018-08-20 | null | N | Y | CARBOPLATIN + FLUOROURACIL | 100678103 |
| 20218161 | 20181539 | 1.51 | 94.5 | null | 2015-01-22 | 2019-11-23 | Gemcitabine + Paclitaxel | 02 | null | CAP + RT | 100382991 |
| 20039998 | 20181540 | 1.52 | 81.6 | Palliative (P) | 2021-09-30 | 2021-10-28 | ARISTOTLE TRIAL | 02 | N | CISPLATIN + FLUOROURACIL + RT | 101839329 |
| 20112612 | 20181542 | 1.97 | 79.2 | Palliative (P) | 2020-03-22 | 2020-05-06 | CAV | 01 | N | CYTARABINE + DAUNORUBICIN | 101479073 |